The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy.
Ural
E
E
Kozdag
G
G
Kilic
T
T
Ural
D
D
Sahin
T
T
Celebi
O
O
Komsuoglu
B
B
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology*; D018660:Blood Pressure Monitoring, Ambulatory; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005215:Fasting / Q000502:physiology*; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007514:Islam; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use; D012068:Religion and Medicine; D014700:Verapamil / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D006852:Hydrochlorothiazide; D001262:Atenolol; D014700:Verapamil; D009543:Nifedipine